Tilray Brands Inc (TLRY)
1.84
0.00 (0.00%)
USD |
NASDAQ |
Apr 24, 16:00
1.84
0.00 (0.00%)
After-Hours: 05:13
Tilray Brands Enterprise Value: 1.586B for April 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 1.586B |
| April 23, 2024 | 1.586B |
| April 22, 2024 | 1.493B |
| April 19, 2024 | 1.500B |
| April 18, 2024 | 1.493B |
| April 17, 2024 | 1.493B |
| April 16, 2024 | 1.578B |
| April 15, 2024 | 1.539B |
| April 12, 2024 | 1.570B |
| April 11, 2024 | 1.632B |
| April 10, 2024 | 1.725B |
| April 09, 2024 | 1.752B |
| April 08, 2024 | 2.166B |
| April 05, 2024 | 2.170B |
| April 04, 2024 | 2.236B |
| April 03, 2024 | 2.367B |
| April 02, 2024 | 2.027B |
| April 01, 2024 | 2.042B |
| March 28, 2024 | 2.073B |
| March 27, 2024 | 2.081B |
| March 26, 2024 | 1.949B |
| March 25, 2024 | 1.825B |
| March 22, 2024 | 1.949B |
| March 21, 2024 | 1.671B |
| March 20, 2024 | 1.694B |
| Date | Value |
|---|---|
| March 19, 2024 | 1.647B |
| March 18, 2024 | 1.647B |
| March 15, 2024 | 1.500B |
| March 14, 2024 | 1.400B |
| March 13, 2024 | 1.454B |
| March 12, 2024 | 1.462B |
| March 11, 2024 | 1.454B |
| March 08, 2024 | 1.477B |
| March 07, 2024 | 1.431B |
| March 06, 2024 | 1.423B |
| March 05, 2024 | 1.438B |
| March 04, 2024 | 1.477B |
| March 01, 2024 | 1.500B |
| February 29, 2024 | 1.500B |
| February 28, 2024 | 1.541B |
| February 27, 2024 | 1.586B |
| February 26, 2024 | 1.533B |
| February 23, 2024 | 1.549B |
| February 22, 2024 | 1.571B |
| February 21, 2024 | 1.564B |
| February 20, 2024 | 1.579B |
| February 16, 2024 | 1.669B |
| February 15, 2024 | 1.617B |
| February 14, 2024 | 1.609B |
| February 13, 2024 | 1.556B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
562.09M
Minimum
Mar 18 2020
9.965B
Maximum
Jun 09 2021
2.683B
Average
1.840B
Median
Aug 03 2023
Enterprise Value Benchmarks
| Clever Leaves Holdings Inc | 1.283M |
| Flora Growth Corp | 14.14M |
| Acasti Pharma Inc | 2.144M |
| Aurinia Pharmaceuticals Inc | 376.94M |
| Edesa Biotech Inc | 9.403M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -92.70M |
| Revenue (Quarterly) | 188.34M |
| Total Expenses (Quarterly) | 221.71M |
| EPS Diluted (Quarterly) | -0.12 |
| Gross Profit Margin (Quarterly) | 26.23% |
| Profit Margin (Quarterly) | -49.22% |
| Earnings Yield | -23.91% |
| Normalized Earnings Yield | -28.61 |